Effect of phenolic and chlorine disinfectants on hepatitis C virus binding and infectivity

American Journal of Infection Control

Volumn 27, Issue 3, 1999, Pages 236-239

  Agolini, Giuliano ^b   Russo, Antonello ^a   Clementi, Massimo ^b  

^a Eurospital SpA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE DERIVATIVE; DISINFECTANT AGENT; PHENOL DERIVATIVE; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEPATITIS C; HEPATITIS C VIRUS; NONHUMAN; VIRUS ADSORPTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0033063626     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1053/ic.1999.v27.a90911     Document Type: Article

References (15)

1. 1. Klein M, Deforest A. Principles of viral inactivation. In: Block SS, editor. Disinfection sterilization and preservation. 3rd Ed. Philadelphia (PA): Lea & Febiger; 1983. p. 422-34.
2. 2. Agolini G. Clementi M. Considerazioni teoriche e valutazioni pratiche della virucidia di disinfettanti ospedalieri. L'Ospedale 1993;46:195-204.
3. 3. Miller RH, Purcell RH. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus super groups. Proc Natl Acad Sci U S A 1990;87:2057-62.
4. 4. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:1463-6.
5. 5. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA. 1992;89:5477-81.
6. 6. Bertolini L, Iacovacci S, Ponzetto A, Gorini G, Battaglia M, Carloni G. The human bone-marrow-derived B cell line CE susceptible to hepatitis C virus infection. Res Virol 1993;144:281-5.
7. 7. Kato N, Nakazawa T, Mizutani T, Shimitohno K. Susceptibility of human T lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun 1995;206:863-9.
8. 8. Carloni G, Iacovacci S, Sargiacomo M, Ravagnan G, Ponzetto A, Peschle C, et al. Susceptibility of human liver cell cultures to hepatitis C virus infection. Arch Virol Suppl 1993;8:31-9.
9. 9. Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 1994;202:606-14.
10. 10. Iacovacci S, Manzin A, Barca S, Sargiacomo M, Serafino A, Valli MB, et al. Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology. In press 1997.
11. 11. Valli MB, Carloni G, Manzin A, Nassori F, Ponzetto A, Clementi M. Hepatitis C virus infection of a VERO cell clone displaying efficient virus-cell binding. Res Virol 1997;148:181-6.
12. 12. Coates D. Uses of sodium dichloroisocyanurate granules for spills of body fluids. J Hosp Infect 1989;131:241-51.
13. 13. Manzin A, Bagnarelli P, Menzo S, Giostra F, Brugia M, Francesconi R, et al. Quantitation of HCV genome molecules in plasma samples. J Clin Microbiol 1994;32:1939-44.
14. 14. Shimizu YK, Purcell RH, Yoshikura H. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci U S A 1993;91:6037-40.
15. 15. Chomczynsky P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 1987;162:156-9.